# Lumiata

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lumiata

- Industry: Software
- Headquarters: San Mateo, US
- Website: www.lumiata.com
- Total disclosed funding: $44M
- Latest round: Series B (Dec 21, 2020)
- Investors on record: 9

## About

Lumiata Inc. is a technology company that specializes in advanced data analytics solutions for healthcare, aiming to improve patient outcomes and operational efficiencies through predictive analytics and innovative health management tools.Founded in 2013 and headquartered in San Mateo, US, Lumiata Inc. focuses on providing data-driven insights to healthcare organizations. The company has received a total of USD 14.00 mn in funding, with its latest funding round being a Series B raise of USD 14.00 mn on December 21, 2020, co-led by Allegis Nl Capital Lp and Defy.vc, with participation from BlueCross BlueShield Venture Partners and Khosla Ventures. The CEO is Dilawar Syed, and the company has completed a total of 5 deals.Lumiata offers a suite of advanced predictive analytics solutions for healthcare providers, enabling them to improve patient care through data-driven insights. Their services include risk stratification, predictive modeling, and clinical support tools designed to enhance decision-making in healthcare delivery, ultimately addressing critical challenges in patient management and operational efficiency.Lumiata generates revenue through partnerships with healthcare organizations, focused on integrating its analytics services into their existing care models. The revenue model is structured around value-based agreements, where compensation is linked to the improvement of patient outcomes and operational efficiency, fostering a sustainable business model that aligns with the healthcare sector's evolving needs.Lumiata plans to leverage its recent Series B funding of USD 14.00 mn to expand its product offerings and enhance existing analytics capabilities. The company aims to enter new geographic markets within the United States by 2022, focusing on collaborations with regional healthcare systems. The funding will also support the development of new predictive tools tailored to emerging healthcare needs.

## Funding rounds

- Series B, Dec 21, 2020, $14M — Khosla Ventures, BlueCross BlueShield Venture Partners, Defy., Allegis Nl Capital Lp
- Series A, Jun 26, 2018, $11M — Intel Capital, Khosla Ventures, BlueCross BlueShield Venture Partners, Sandbox Industries, Alumni Ventures Group, Leawood Venture Capital
- Series B, Apr 8, 2016, $10M — Intel Capital, Khosla Ventures, BlueCross BlueShield Venture Partners, Sandbox Industries
- Series A, Aug 11, 2014, $5M — Khosla Ventures, BlueCross BlueShield Venture Partners, Sandbox Industries, AmeriHealth, Inc.
- Series A, Jul 29, 2013, $4M — Khosla Ventures

## Investors

- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series A, Series B
- BlueCross BlueShield Venture Partners (https://capitalatlas.ai/funds/bluecross-blueshield-venture-partners) — Series A, Series B
- Sandbox Industries (https://capitalatlas.ai/funds/sandbox-industries) — Series A, Series B
- AmeriHealth, Inc. — Series A
- Intel Capital (https://capitalatlas.ai/funds/intel-capital) — Series B, Series A
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series A
- Leawood Venture Capital (https://capitalatlas.ai/funds/leawood-venture-capital) — Series A
- Defy. (https://capitalatlas.ai/funds/defy) — Series B
- Allegis Nl Capital Lp — Series B